CTLA4 and colitis: Moreover, a high-level infiltration of CD4+ T cells and CD8+ T cells was reported in patients with severe colitis following immunotherapy, of which the former was more prevalent in those who underwent anti-CTLA-4 therapy and the latter usually occurred in anti-PD-1-induced colitis (95–97).